RNF4 negatively regulates NF-κB signaling by down-regulating TAB2

FEBS Letters

Volumn 589, Issue 19, 2015, Pages 2850-2858

  Tan, Bo ^a   Mu, Rui ^a   Chang, Yan ^a   Wang, Yu Bo ^a   Wu, Min ^a   Tu, Hai Qing ^a   Zhang, Yu Cheng ^a   Guo, Sai Sai ^a   Qin, Xuan He ^a   Li, Tao ^a   Li, Wei Hua ^a   Zhang, Xue Min ^a   Li, Ai Ling ^a   Li, Hui Yan ^a  

^a NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

Abbreviations NF B nuclear factor kappa B; IL 1 interleukin 1 beta; TNF tumor necrosis factor alpha

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; RING FINGER PROTEIN; RING FINGER PROTEIN 4; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; INTERLEUKIN 1BETA; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NUCLEAR PROTEIN; RNF4 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TAB2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; LYSOSOME; METABOLISM; MOUSE; PROTEIN DEGRADATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; LYSOSOMES; MAP KINASE KINASE KINASES; MICE; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 84941427009     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.07.051     Document Type: Article

References (26)

1. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436
2. M.S. Hayden, and S. Ghosh NF-kappaB, the first quarter-century: remarkable progress and outstanding questions Genes Dev. 26 2012 203 234
3. J.A. DiDonato, F. Mercurio, and M. Karin NF-kappaB and the link between inflammation and cancer Immunol. Rev. 246 2012 379 400
4. G. Chen, and D.V. Goeddel TNF-R1 signaling: a beautiful pathway Science 296 2002 1634 1635
5. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ. 10 2003 45 65
6. S. Ghosh, and M.S. Hayden Celebrating 25 years of NF-kappaB research Immunol. Rev. 246 2012 5 13
7. Z.J. Chen Ubiquitination in signaling to and activation of IKK Immunol. Rev. 246 2012 95 106
8. A.L. Chernorudskiy, and M.R. Gainullin Ubiquitin system: direct effects join the signaling Sci. Signal. 6 2013 pe22
9. I.E. Wertz, K.M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P. Wu, C. Wiesmann, R. Baker, D.L. Boone, A. Ma, E.V. Koonin, and V.M. Dixit De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling Nature 430 2004 694 699
10. A. Kovalenko, C. Chable-Bessia, G. Cantarella, A. Israel, D. Wallach, and G. Courtois The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination Nature 424 2003 801 805
11. H.Y. Li, H. Liu, C.H. Wang, J.Y. Zhang, J.H. Man, Y.F. Gao, P.J. Zhang, W.H. Li, J. Zhao, X. Pan, T. Zhou, W.L. Gong, A.L. Li, and X.M. Zhang Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1 Nat. Immunol. 9 2008 533 541
12. Y.B. Wang, B. Tan, R. Mu, Y. Chang, M. Wu, H.Q. Tu, Y.C. Zhang, S.S. Guo, X.H. Qin, T. Li, W.H. Li, A.L. Li, X.M. Zhang, and H.Y. Li Ubiquitin-associated domain-containing UBX protein UBXN1 is a negative regulator of NF-kappaB signaling J. Biol. Chem. 2015
13. V. Lallemand-Breitenbach, M. Jeanne, S. Benhenda, R. Nasr, M. Lei, L. Peres, J. Zhou, J. Zhu, B. Raught, and H. de The Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway Nat. Cell Biol. 10 2008 547 555
14. M.H. Tatham, M.C. Geoffroy, L. Shen, A. Plechanovova, N. Hattersley, E.G. Jaffray, J.J. Palvimo, and R.T. Hay RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation Nat. Cell Biol. 10 2008 538 546
15. S.R. Weisshaar, K. Keusekotten, A. Krause, C. Horst, H.M. Springer, K. Gottsche, R.J. Dohmen, and G.J. Praefcke Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML FEBS Lett. 582 2008 3174 3178
16. N. Martin, K. Schwamborn, V. Schreiber, A. Werner, C. Guillier, X.D. Zhang, O. Bischof, J.S. Seeler, and A. Dejean PARP-1 transcriptional activity is regulated by sumoylation upon heat shock EMBO J. 28 2009 3534 3548
17. Y. Galanty, R. Belotserkovskaya, J. Coates, and S.P. Jackson RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair Genes Dev. 26 2012 1179 1195
18. R. Vyas, R. Kumar, F. Clermont, A. Helfricht, P. Kalev, P. Sotiropoulou, I.A. Hendriks, E. Radaelli, T. Hochepied, C. Blanpain, A. Sablina, H. van Attikum, J.V. Olsen, A.G. Jochemsen, A.C. Vertegaal, and J.C. Marine RNF4 is required for DNA double-strand break repair in vivo Cell Death Differ. 20 2013 490 502
19. Y. Yin, A. Seifert, J.S. Chua, J.F. Maure, F. Golebiowski, and R.T. Hay SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage Genes Dev. 26 2012 1196 1208
20. E.W. Harhaj, and V.M. Dixit Regulation of NF-kappaB by deubiquitinases Immunol. Rev. 246 2012 107 124
21. F. Tokunaga, S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako, K. Kamei, T. Nakagawa, M. Kato, S. Murata, S. Yamaoka, M. Yamamoto, S. Akira, T. Takao, K. Tanaka, and K. Iwai Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation Nat. Cell Biol. 11 2009 123 132
22. M.A. Maroui, S. Kheddache-Atmane, F. El Asmi, L. Dianoux, M. Aubry, and M.K. Chelbi-Alix Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms PLoS ONE 7 2012 e44949
23. M. Shi, W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation Nat. Immunol. 9 2008 369 377
24. M.M. Hu, Q. Yang, J. Zhang, S.M. Liu, Y. Zhang, H. Lin, Z.F. Huang, Y.Y. Wang, X.D. Zhang, B. Zhong, and H.B. Shu TRIM38 inhibits TNFalpha- and IL-1beta-triggered NF-kappaB activation by mediating lysosome-dependent degradation of TAB2/3 Proc. Natl. Acad. Sci. U.S.A. 111 2014 1509 1514
25. Z.J. Chen Ubiquitin signalling in the NF-kappaB pathway Nat. Cell Biol. 7 2005 758 765
26. A. Besse, B. Lamothe, A.D. Campos, W.K. Webster, U. Maddineni, S.C. Lin, H. Wu, and B.G. Darnay TAK1-dependent signaling requires functional interaction with TAB2/TAB3 J. Biol. Chem. 282 2007 3918 3928